PRINTER'S NO. 2971
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
2092
Session of
2019
INTRODUCED BY SAPPEY, ISAACSON, KINSEY, HANBIDGE, FREEMAN, MURT,
VITALI, SHUSTERMAN, ZABEL, SCHWEYER, GALLOWAY, DeLUCA,
O'MARA, CIRESI, HOWARD, HILL-EVANS AND OTTEN,
DECEMBER 2, 2019
REFERRED TO COMMITTEE ON HEALTH, DECEMBER 2, 2019
AN ACT
Amending the act of September 27, 1961 (P.L.1700, No.699),
entitled "An act relating to the regulation of the practice
of pharmacy, including the sales, use and distribution of
drugs and devices at retail; and amending, revising,
consolidating and repealing certain laws relating thereto,"
further providing for State Board of Pharmacy.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 6(k)(9) of the act of September 27, 1961
(P.L.1700, No.699), known as the Pharmacy Act, is amended to
read:
Section 6. State Board of Pharmacy.--* * *
(k) The board shall have the power, and it shall be its
duty:
* * *
(9) To promulgate rules and regulations to effectuate the
purposes of this act and to regulate the distribution of drugs
and devices and the practice of pharmacy for the protection and
promotion of the public health, safety and welfare.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Notwithstanding any other law or regulation, the rules and
regulations promulgated under this paragraph shall include
provisions requiring warning labels on containers used by a
pharmacist or nonresident pharmacy to dispense a prescription
for a controlled substance or other drug that contains an
opiate. The warning label requirement shall not apply if the
opiate is to be administered to a patient in an institution. For
the purposes of this clause, the term "opiate" shall have the
meaning given to it in section 2 of the act of April 14, 1972
(P.L.233, No.64), known as "The Controlled Substance, Drug,
Device and Cosmetic Act." The regulations shall include:
(i) Information regarding the location, color and size of
the warning label.
(ii) The content of the warning label, which shall be in a
bold, easily readable font and shall be the same as or similar
to the following warning: "This drug is or contains an opiate,
which carries a high risk of addiction, overdose and death."
* * *
Section 2. Any regulations inconsistent with this act are
abrogated to the extent of any inconsistency with this act.
Section 3. This act shall take effect in 60 days.
20190HB2092PN2971 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21